Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease

Cardiovascular Research

Volumn 103, Issue 4, 2014, Pages 461-472

  Eirin, Alfonso ^a   Ebrahimi, Behzad ^a   Zhang, Xin ^a   Zhu, Xiang Yang ^a   Woollard, John R ^a   He, Quan ^b   Textor, Stephen C ^a   Lerman, Amir ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Atherosclerosis; Hypertension; Mitochondria; Renal

Indexed keywords

BENDAVIA; CARDIOLIPIN; TERT BUTYL HYDROPEROXIDE; TETRAPEPTIDE; UNCLASSIFIED DRUG; ARGINYL-2,'6'-DIMETHYLTYROSYL-LYSYL-PHENYLALANINAMIDE; OLIGOPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC RENOVASCULAR DISEASE; CELL FUNCTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOMESTIC PIG; ENDOTHELIUM CELL; EX VIVO STUDY; GLOMERULUS FILTRATION RATE; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY FUNCTION; MASS SPECTROMETRY; NEPHROSCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; OXYGENATION; PRIORITY JOURNAL; RENAL ARTERY; SOLITARY KIDNEY; SWINE DISEASE; ANIMAL; ATHEROSCLEROSIS; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; FEMALE; KIDNEY CIRCULATION; KIDNEY DISEASES; METABOLISM; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG; RENOVASCULAR HYPERTENSION;

ANIMALS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; GLOMERULAR FILTRATION RATE; HYPERTENSION, RENOVASCULAR; KIDNEY DISEASES; MITOCHONDRIA; OLIGOPEPTIDES; OXIDATIVE STRESS; RENAL CIRCULATION; SWINE;

EID: 84907336761     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu157     Document Type: Article

References (41)

1. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 2001;60: 1490-1497.
2. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2013;370: 13-22.
3. Kluge MA, Fetterman JL, Vita JA. Mitochondria and endothelial function. Circ Res 2013; 112: 1171-1188.
4. ZhuXY, Chade AR, Rodriguez-Porcel M, BentleyMD, Ritman EL, Lerman A, Lerman LO. Cortical microvascular remodeling in the stenotic kidney: role of increased oxidative stress. Arterioscler Thromb Vasc Biol 2004;24: 1854-1859.
5. Klingenberg M. Cardiolipin and mitochondrial carriers. Biochim Biophys Acta 2009;1788: 2048-2058.
6. van Gestel RA, Rijken PJ, Surinova S, O'Flaherty M, Heck AJ, Killian JA, de Kroon AI, Slijper M. The influence of the acyl chain composition of cardiolipin on the stability of mitochondrial complexes; an unexpected effect of cardiolipin in alpha-ketoglutarate dehydrogenase and prohibitin complexes. J Proteomics 2010;73: 806-814.
7. Schug ZT, Gottlieb E. Cardiolipin acts as a mitochondrial signalling platform to launch apoptosis. Biochim Biophys Acta 2009;1788: 2022-2031.
8. Petrosillo G, Moro N, Ruggiero FM, Paradies G. Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release. Free Radic Biol Med 2009;47: 969-974.
9. Shidoji Y, Hayashi K, Komura S, Ohishi N, Yagi K. Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. Biochem Biophys Res Commun 1999;264: 343-347.
10. Petrosillo G, Ruggiero FM, Paradies G. Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J 2003;17: 2202-2208.
11. BirkAV, Liu S, SoongY, MillsW, Singh P, Warren JD, Seshan SV, Pardee JD, Szeto HH. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol 2013;24: 1250-1261.
12. Dai DF, Chen T, Szeto H, Nieves-Cintron M, Kutyavin V, Santana LF, Rabinovitch PS. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol 2011;58: 73-82.
13. Kloner RA, Hale SL, Dai W, Gorman RC, Shuto T, Koomalsingh KJ, Gorman JH III, Sloan RC, Frasier CR, Watson CA, Bostian PA, Kypson AP, Brown DA. Reduction of ischemia/ reperfusion injury with Bendavia, a mitochondria-targeting cytoprotective peptide. J Am Heart Assoc 2012;1: e001644.
14. Sloan RC, Moukdar F, Frasier CR, Patel HD, Bostian PA, Lust RM, BrownDA. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury. J Mol Cell Cardiol 2012;52: 1009-1018.
15. Mizuguchi Y, Chen J, Seshan SV, Poppas DP, Szeto HH, Felsen D. A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am J Physiol Renal Physiol 2008;295: F1545-F1553.
16. Szeto HH, Liu S, Soong Y, Wu D, Darrah SF, Cheng FY, Zhao Z, Ganger M, Tow CY, Seshan SV. Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 2011;22: 1041-1052.
17. Eirin A, Li Z, Zhang X, Krier JD, Woollard JR, Zhu XY, Tang H, Herrmann SM, Lerman A, Textor SC, Lerman LO.Amitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension 2012;60: 1242-1249.
18. Daghini E, Primak AN, Chade AR, Krier JD, Zhu XY, Ritman EL, McCollough CH, Lerman LO. Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT. Radiology 2007;243: 405-412.
19. Ebrahimi B, Li Z, Eirin A, Zhu XY, Textor SC, Lerman LO. Addition of endothelial progenitor cells to renal revascularization restores medullary tubular oxygen consumption in swine renal artery stenosis. Am J Physiol Renal Physiol 2012;302: F1478-F1485.
20. Eirin A, ZhuXY, Urbieta-Caceres VH, Grande JP, Lerman A, Textor SC, Lerman LO. Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling. Am J Physiol Renal Physiol 2011;300: F1394-F1401.
21. Eirin A, Zhu XY, Krier JD, Tang H, Jordan KL, Grande JP, Lerman A, Textor SC, Lerman LO. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 2012;30: 1030-1041.
22. Zhao K, Luo G, Giannelli S, Szeto HH. Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem Pharmacol 2005;70: 1796-1806.
23. Pipinos II, Nypaver TJ, Moshin SK, Careterro OA, Beierwaltes WH. Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis. J Vasc Surg 1998;28: 167-177.
24. Eirin A, Lerman LO. Darkness at the end of the tunnel: poststenotic kidney injury. Physiology (Bethesda) 2013;28: 245-253.
25. Fedorova LV, Sodhi K, Gatto-Weis C, Puri N, Hinds TD Jr, Shapiro JI, Malhotra D. Peroxisome proliferator-activated receptor delta agonist, hpp593, prevents renal necrosis under chronic ischemia. PLoS ONE 2013;8: e64436.
26. Zhang M, Mileykovskaya E, DowhanW. Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 2002;277: 43553-43556.
27. Szeto HH. Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal 2008;10: 601-619.
28. Schlame M. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J Lipid Res 2008;49: 1607-1620.
29. Li J, Romestaing C, Han X, Li Y, Hao X, Wu Y, Sun C, Liu X, Jefferson LS, Xiong J, Lanoue KF, Chang Z, Lynch CJ, Wang H, Shi Y. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab 2010;12: 154-165.
30. Gonzalvez F, Schug ZT, Houtkooper RH, MacKenzie ED, Brooks DG, Wanders RJA, Petit PX, Vaz FM, Gottlieb E. Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol 2008;183: 681-696.
31. Babior BM. NADPH oxidase. Curr Opin Immunol 2004;16: 42-47.
32. Duan S-B, Yang S-K, Zhou Q-Y, Pan P, Zhang H, Liu F, Xu X-Q. Mitochondria-targeted peptides prevent on contrast-induced acute kidney injury in the rats with hypercholesterolemia. Ren Fail 2013;35: 1124-1129.
33. Chade AR, Kelsen S. Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach. Am J Physiol Renal Physiol 2012;302: F1342-F1350.
34. Chade AR, Kelsen S. Renal microvascular disease determines the responses to revascularization in experimental renovascular disease. Circ Cardiovasc Interv 2010;3: 376-383.
35. Benest AV, Salmon AH, WangW, Glover CP, Uney J, Harper SJ, Bates DO. VEGF and angiopoietin-1 stimulate different angiogenic phenotypes that combine to enhance functional neovascularization in adult tissue. Microcirculation 2006;13: 423-437.
36. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation 2005;112: 1362-1374.
37. Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, Romero JC, Napoli C, Lerman LO. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 2002;106: 1165-1171.
38. Chade AR, Rodriguez-Porcel M, Grande JP, Zhu X, Sica V, Napoli C, Sawamura T, Textor SC, Lerman A, Lerman LO. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 2003;23: 1295-1301.
39. Chade AR, Rodriguez-Porcel M, Herrmann J, Zhu X, Grande JP, Napoli C, Lerman A, Lerman LO. Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol 2004;15: 958-966.
40. Jacobson J, Duchen MR, Heales SJ. Intracellular distribution of the fluorescent dye nonyl acridine orange responds to the mitochondrial membrane potential: implications for assays of cardiolipin and mitochondrial mass. J Neurochem 2002;82: 224-233.
41. Oliveira HC, Cosso RG, Alberici LC, Maciel EN, Salerno AG, Dorighello GG, Velho JA, de Faria EC, Vercesi AE. Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria. FASEB J 2005;19: 278-280.